Therapeutic Asset Ratings
178 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Zanubrutinib
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
Northwestern University
P2
CCC
(53)
Zanubrutinib
Primary Mediastinal Large B-Cell Lymphoma
Northwestern University
P2
CCC
(53)
Zanubrutinib
Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
Northwestern University
P2
CCC
(53)
Zanubrutinib
T-Cell/Histiocyte Rich Large B Cell Lymphoma
Northwestern University
P2
CCC
(53)
Zanubrutinib
Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
Northwestern University
P2
CCC
(53)
Z/E 4-HYDROXY TAMOXIFEN
Cancer
Northwestern University
P2
CCC
(53)
Z/E 4-HYDROXY TAMOXIFEN
Invasive Breast Carcinoma
Northwestern University
P2
CCC
(53)
carbidopa
Chronic Pain
Northwestern University
P2
CCC
(51)
Devimistat
Exocrine Pancreatic Carcinoma
Northwestern University
P2
CCC
(51)
Devimistat
Malignant Pancreatic Neoplasm
Northwestern University
P2
CCC
(51)
GADOBENATE DIMEGLUMINE
Prostate Carcinoma
Northwestern University
P2
CCC
(51)
LEVODOPA
Chronic Pain
Northwestern University
P2
CCC
(51)
Lipitor
Colorectal Carcinoma
Northwestern University
P2
CCC
(51)
Lisinopril
Hepatocellular Carcinoma
Northwestern University
P2
CCC
(48)
BMS-986504
Biliary Tract Cancer
Northwestern University
P1/2
CCC
(48)
BMS-986504
Colon Carcinoma
Northwestern University
P1/2
CCC
(48)
BMS-986504
Carcinoma Of Esophagus
Northwestern University
P1/2
CCC
(48)
BMS-986504
Digestive System Cancer
Northwestern University
P1/2
CCC
(48)
METHOTREXATE
High Grade B-Cell Lymphoma
Northwestern University
P1/2
CCC
(48)
Devimistat
Biliary Tract Cancer
Northwestern University
P2
CC
(47)
Devimistat
Colorectal Carcinoma
Northwestern University
P2
CC
(47)
Devimistat
Gastroesophageal Junction Adenocarcinoma
Northwestern University
P2
CC
(47)
Devimistat
Lung Adenocarcinoma
Northwestern University
P2
CC
(47)
Devimistat
Advanced Malignant Solid Neoplasm
Northwestern University
P2
CC
(47)
Devimistat
Ovarian Carcinoma
Northwestern University
P2
CC
(47)
Showing 126 to 150 of 178 assets
Previous
Page 6 of 8
Next